- Home
- NBY vs SHPH Comparison
NBY vs SHPH Comparison
Compare NBY & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- SHPH
- Stock Information
- Founded
- NBY 2000
- SHPH 2012
- Country
- NBY United States
- SHPH United States
- Employees
- NBY N/A
- SHPH N/A
- Industry
- NBY
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- NBY
- SHPH Health Care
- Exchange
- NBY Nasdaq
- SHPH Nasdaq
- Market Cap
- NBY 3.3M
- SHPH 2.7M
- IPO Year
- NBY 2007
- SHPH 2022
- Fundamental
- Price
- NBY $0.53
- SHPH $0.64
- Analyst Decision
- NBY Strong Buy
- SHPH
- Analyst Count
- NBY 1
- SHPH 0
- Target Price
- NBY $0.85
- SHPH N/A
- AVG Volume (30 Days)
- NBY 78.3K
- SHPH 73.1K
- Earning Date
- NBY 11-07-2024
- SHPH 11-13-2024
- Dividend Yield
- NBY N/A
- SHPH N/A
- EPS Growth
- NBY N/A
- SHPH N/A
- EPS
- NBY N/A
- SHPH N/A
- Revenue
- NBY $13,844,000.00
- SHPH N/A
- Revenue This Year
- NBY N/A
- SHPH N/A
- Revenue Next Year
- NBY $26.04
- SHPH N/A
- P/E Ratio
- NBY N/A
- SHPH N/A
- Revenue Growth
- NBY 15.40
- SHPH N/A
- 52 Week Low
- NBY $0.36
- SHPH $0.61
- 52 Week High
- NBY $10.15
- SHPH $4.94
- Technical
- Relative Strength Index (RSI)
- NBY 35.25
- SHPH 27.09
- Support Level
- NBY $0.52
- SHPH $0.61
- Resistance Level
- NBY $0.58
- SHPH $0.79
- Average True Range (ATR)
- NBY 0.03
- SHPH 0.06
- MACD
- NBY -0.00
- SHPH 0.00
- Stochastic Oscillator
- NBY 11.56
- SHPH 12.15
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.